Andreas Halvorsen

Stock price provided by Lang & Schwarz

Showing transactions by Andreas Halvorsen in BioMarin Pharmaceutical Inc..

Quarter	Type	Shares before	Shares after	Change	Price range
2025-Q1	Buy	11M	11M	+290K	€59.44–€68.61
2024-Q4	Buy	9.8M	11M	+757K	€58.50–€65.78
2024-Q3	Buy	7.1M	9.8M	+2.7M	€60.82–€84.52
2024-Q2	Buy	6.4M	7.1M	+647K	€69.32–€86.86
2024-Q1	Buy	4.9M	6.4M	+1.5M	€76.80–€89.04
2023-Q4	Buy	4.2M	4.9M	+674K	€71.04–€89.18
2023-Q3	Buy	4.2M	4.2M	+59K	€75.26–€87.28
2023-Q2	Buy	2.2M	4.2M	+2M	€81.24–€91.42
2023-Q1	Sell	5.3M	2.2M	-3.1M	€82.63–€107.46
2022-Q4	Buy	5.1M	5.3M	+174K	€80.73–€102.22
2022-Q3	Buy	5.1M	5.1M	+47K	€81.52–€94.98
2022-Q2	Buy	3.8M	5.1M	+1.3M	€68.39–€82.53
2022-Q1	Buy	2.9M	3.8M	+882K	€68.28–€80.98
2021-Q4	Buy	1.5M	2.9M	+1.4M	€62.06–€81.40
2020-Q1	Sell	1.6M	1.5M	-168K	€65.17–€87.71
2019-Q4	Sell	3.1M	1.6M	-1.4M	€58.65–€76.67
2019-Q3	Buy	2.6M	3.1M	+468K	€62.00–€76.31
2019-Q2	Sell	5.1M	2.6M	-2.5M	€71.11–€83.47
2019-Q1	Buy	5.1M	5.1M	+37K	€73.73–€85.82
2018-Q4	Buy	4.1M	5.1M	+963K	€71.14–€92.03
2018-Q3	Buy	3.3M	4.1M	+869K	€79.97–€90.45
2018-Q2	Buy	1.7M	3.3M	+1.6M	€62.33–€84.93
2018-Q1	Buy	260K	1.7M	+1.4M	€63.61–€76.50
2017-Q2	Sell	876K	260K	-616K	€76.96–€88.56
2017-Q1	Sell	1.4M	876K	-522K	€77.82–€89.19
2016-Q4	Buy	490K	1.4M	+908K
2016-Q3	Sell	602K	490K	-112K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors